longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Why Is Venus Concept Stock Plunging Today?

benzinga_article
Jan 21, 2026 at 05:50 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Venus Concept Inc. announced it will voluntarily delist from Nasdaq and deregister with the SEC, leading to a 54.83% drop in its stock price to $2.00. The decision, driven by high compliance costs, will result in the suspension of periodic SEC reporting. The last trading day on Nasdaq is expected around February 6, 2026. CEO Rajiv De Silva stated this move is in the best interests of the company and its shareholders, as they continue to work with Madryn Asset Management for long-term financial success.

Venus Concept Inc. (NASDAQ:VERO) shares fell on Wednesday after the company said it will voluntarily delist from Nasdaq and end SEC reporting.

The board notified Nasdaq that it plans to leave the Nasdaq Capital Market and deregister with the SEC, citing compliance costs that outweigh the benefits of staying listed.

As of September 30, 2025, the company's inventories totaled $15.768 million. Cash and equivalents totaled $4.312 million.

Where And When It Happens

Venus Concept said it plans to file a Form 25 with the SEC on or about January 30, 2026.

The company expects its last day of trading on Nasdaq to be on or about February 6, 2026.

The company also plans to file a Form 15 on or about February 9, 2026. That filing will immediately suspend its obligation to submit periodic SEC reports, including Forms 10-K, 10-Q and 8-K.

The board said it reviewed the cost of ongoing SEC reporting and determined it exceeds the value of remaining publicly listed.

"The Board of Directors, after thorough evaluation, has determined this action is in the best interests of the Company and its shareholders," said Rajiv De Silva, chief executive officer of Venus Concept.

He said the company will continue working with Madryn Asset Management to support long-term financial success.

Venus Concept sells medical aesthetic technology, including minimally invasive and non-invasive devices, in more than 60 countries.

Its portfolio includes Venus NOVA, Venus Versa and the ARTAS iX robotic hair restoration system.

VERO Price Action: Venus Concept shares were down 54.83% at $2.00 at the time of publication on Wednesday. The stock is near its 52-week low of $1.39, according to Benzinga Pro data.

Image via Shutterstock

Login to unlock1,259characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Feb 23, 2026 at 01:57 PMGlobal news you need to know before Monday's U.S. stock market opens
  • Feb 11, 2026 at 01:54 AMWhen AI enters hospitals, risks such as "surgical errors and misidentification of organs" also arise
  • Feb 4, 2026 at 12:43 PMWeight loss drug sales explode! Eli Lilly's Q4 revenue increased by 43% year-on-year, net profit grew by 50%, and the re…
  • Feb 3, 2026 at 07:16 AMUS stocks "first surge then crash"? US Treasury yields break 5%, technology lags behind pharmaceuticals... The "top ten …
  • Jan 26, 2026 at 08:12 AMAI empowerment + patent expirations, 2026 will be an exciting year for healthcare private equity!

Related Stocks

Venus Concept

Venus Concept

USVERO

0.00%

iShares US Medical Devices

iShares US Medical Devices

USIHI

SPDR S&P Health Equip

SPDR S&P Health Equip

USXHE

LongbridgeAI